X4 Pharmaceuticals, Inc - XFOR
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 16
Latest filed: Jul 01, 2026
| Form | Count |
|---|---|
| SCHEDULE 13G/A | 7 |
| 4 | 3 |
| 8-K | 2 |
| SCHEDULE 13G | 2 |
| 8-K/A | 1 |
| 144 | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Jul 01, 2026 | 8-K | Jun 30, 2026 | 0001501697-26-000060 | View |
| Jul 01, 2026 | 4 | Jul 01, 2026 | 0001501697-26-000064 | View |
| Jul 01, 2026 | 4 | Jun 30, 2026 | 0001501697-26-000065 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001193125-26-226568 | View |
| May 13, 2026 | 8-K/A | May 11, 2026 | 0001501697-26-000051 | View |
| May 13, 2026 | 4 | May 12, 2026 | 0001501697-26-000049 | View |
| May 12, 2026 | 144 | — | 0001276750-26-000004 | View |
| May 12, 2026 | 8-K | May 11, 2026 | 0001501697-26-000047 | View |
| Mar 06, 2026 | SCHEDULE 13G/A | — | 0000895421-26-000094 | View |
| Feb 17, 2026 | SCHEDULE 13G | — | 0001104659-26-016241 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001193125-26-054779 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001493152-26-007144 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0000921895-26-000476 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | — | 0001104659-26-015354 | View |
| Feb 12, 2026 | SCHEDULE 13G | — | 0000895421-26-000068 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | — | 0000315066-26-000584 | View |